Navigation Links
Accuray Announces Results for First Quarter Fiscal 2012
Date:11/8/2011

retention expenses, $1.0 million of charges related to preparation for integration of work forces and operations, and $0.5 million charge for property, plant and equipment revaluation.

Net Loss Attributable to StockholdersGAAP Q1'12AdjustmentsNon-GAAP Q1'12Pro forma Combined Results Q1'11Loss From Operations

$
(24,687)$
4,821

(H)

$
(9,866)$
(21,737) Other income (expense), net

(2,858)639

(I)

(2,219)3,493Provision For Income Taxes

538-538174Noncontrolling Interest

(1,573)-(1,573)(1,842)Net Loss Attributable to Stockholders$
(26,510)$
5,460$
(11,050)$
(16,576)Net Loss Per Share - Basic and Diluted

$
(0.38)$
.22$
(0.16)$
(0.24)Weighted Average Common Shares outstanding - Basic and Diluted70,26370,26367,780(J)(H) Represents impact of all adjustments (A) through (G) on Loss From Operations.

(I) Represents non-cash interest expense arising from the accretion of interest expense on the long-term debt..

(J) Represents weighted average common shares outstanding used to compute our basic and diluted net loss per share as disclosed in our Form 10Q for the quarter ended September 30, 2010, adjusted to reflect the acquisition of TomoTherapy as if it occurred on July 1, 2010.

Pro forma financial tables Tables below represent combined total financial results as previously reported by Accuray and TomoTherapy separately for the quarter ended September 30, 2010.

RevenuesAccuray Q1'11Tomo Q1'11CombinedProducts$
9,916$
29,759$   49,675Services17,73413,82331,557Other418-418Total$
38,068$
43,582$   81,650Cost of RevenuesAccuray Q1'11Tomo Q1'11CombinedProducts$
7,497$
,233$   23,730Services11,80020,33932,139Other534-534Total$
9,831$
36,572$   56,403Gross ProfitAccuray Q1'11Tomo Q1'11CombinedProducts$
2,419$
3,526$   25,945Services5,934(6,516)(582)Other(116)-(116)Total$
8,237$
7,010$ 
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
2. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
3. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
4. Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009
5. Accuray Postpones Release of First Quarter Fiscal 2009 Results
6. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
7. Accuray Incorporateds CEO to Speak at 27th Annual JP Morgan Healthcare Conference
8. Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results
9. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
10. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
11. Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Continental Clinical Solutions, LLC (Continental) focuses ... at its mid-Atlantic late-phase research facility, located in ... the idea of closing patient disparities in mind. ... advances," said Continental's CEO, Saleh Stevens . ... cell line of Henrietta Lacks, dubious ethical practices ...
(Date:11/24/2014)... Senior Vice President, General Manager ... skills, business acumen Elsevier , a ... and services, congratulates Diane Bartoli , Senior Vice ... Elsevier Clinical Solutions, for being recognized in the 13 ... issue of Profiles in Diversity Journal ® ...
(Date:11/22/2014)... November 21, 2014 Prominent academics, ... will gather on December 3rd at Genetic Rx, ... series. GeneticRx will take place at the Joseph ... and will discuss the present and future of ... skipping, and gene editing—as well as the treatment ...
(Date:11/22/2014)... The “Chiral Chromatography Columns Market by type ... Plastic), by Application [GC, LC (HPLC, UHPLC, Flash ... analyses and studies the major market drivers, restraints, ... and Rest of the World. , Browse 90 ... 135 pages and in-depth TOC on “Chiral Chromatography ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... and WILMINGTON, Del., Sept. 22 For,his lifetime commitment ... of,radiation and other environmental exposures on the developing fetus ... education, Robert,L. Brent, MD, PhD, will be honored as ... for Excellence in Children,s Health Care by Nemours,one of ...
... Preclinical Research at Upcoming Conferences, CALGARY, Sept. ... ONCY) today announced the participation of five of ... conferences,through November 15, 2008 covering clinical trial results ... time for Oncolytics as we begin to share ...
... Names Industry Veteran as Executive Director, INDIANAPOLIS, ... management, clinical, and pharmaceutical testing facility,is announcing the ... industry veteran to lead the division. AIT has ... of West Lafayette-based,Bioanalytical Systems, Inc. (Nasdaq: BASI ...
Cached Biology Technology:Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Children's Health Care 2Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial 2Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial 3AIT Laboratories Expands Pharma Services 2AIT Laboratories Expands Pharma Services 3
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... 2012 Chemicals in the environment that mimic estrogen ... animals. New research to be presented at the 2012 ... in Madison, Wisconsin, reveals that these substances may act ... stages of embryonic development. Estrogenic compounds in the ...
... Autism Speaks, the world,s leading autism science and advocacy ... totaling nearly $2.9 million in funding to support autism ... Speaks, not only for funding research projects which have ... said Autism Speaks Co-founder Bob Wright, "but in supporting ...
... Mich.A dry spring in portions of the Midwest is expected ... on record in 2012, according to a University of Michigan ... 2012 Gulf of Mexico dead zone of about 1,200 square ... forecast is correct, 2012 would replace 2000 (1,696 square miles) ...
Cached Biology News:Environmental estrogens affect early developmental activity in zebrafish 2Environmental estrogens affect early developmental activity in zebrafish 3Autism Speaks awards nearly $2.9 million to fund autism research 2Autism Speaks awards nearly $2.9 million to fund autism research 3Autism Speaks awards nearly $2.9 million to fund autism research 4U-M forecasters predict second-smallest Gulf of Mexico 'dead zone' 2U-M forecasters predict second-smallest Gulf of Mexico 'dead zone' 3U-M forecasters predict second-smallest Gulf of Mexico 'dead zone' 4
... is a highly scalable analysis platform ... in a workgroup or an enterprise ... 40 leading pharmaceutical, biotechnology, academic and ... streamlines genomics research at large and ...
... a genome-wide microRNA (miRNA) expression profiling service ... which enable highly sensitive and specific direct ... arrays for mature miRNA of all species ... Sanger miRBase database (Release 8.2). Our service ...
... ProXPRESS 2D Proteomic Imaging System, Basic ... Over a Wide Dynamic Range: The ProXPRESS ... sensitive in imaging system for both proteomic ... 2D provides unparalleled flexibility, enabling the use ...
... These extended-length microarrays are custom designed to ... configurations are available: 8,455 features per array ... 22,575 features per array (1 array/slide). ... probe length - This extended length ...
Biology Products: